KEAP1 and neoplasm: Importantly, the predominant transcriptional regulator of cysteine metabolism—the Keap1/Nrf2 pathway—is mutated in numerous tumor types [120,121,122] and can be activated by oncogenic signaling pathways such as KRas and PI3K [123,124], suggesting that downstream control of cysteine metabolism is an important oncogenic function.